vs
Ouster, Inc.（OUST）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Ouster, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.7倍（$62.2M vs $35.5M），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 106.6%），Ouster, Inc.自由现金流更多（$-37.2M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 54.8%）
Ouster, Inc.是总部位于美国加利福尼亚州旧金山的激光雷达技术企业，主打高分辨率数字化3D激光雷达传感器，产品广泛应用于自动驾驶车辆、工业自动化、机器人、无人机、地图测绘、国防及安防等领域。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
OUST vs RXRX — 直观对比
营收规模更大
OUST
是对方的1.7倍
$35.5M
营收增速更快
RXRX
高出575.1%
106.6%
自由现金流更多
OUST
多$10.1M
$-47.3M
两年增速更快
RXRX
近两年复合增速
54.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.2M | $35.5M |
| 净利润 | — | $-108.1M |
| 毛利率 | 60.2% | 59.8% |
| 营业利润率 | 1.5% | -304.8% |
| 净利率 | — | -304.2% |
| 营收同比 | 106.6% | 681.7% |
| 净利润同比 | — | 39.6% |
| 每股收益（稀释后） | $0.10 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OUSTRXRX
| Q4 25 | $62.2M | $35.5M | ||
| Q3 25 | $39.5M | $5.2M | ||
| Q2 25 | $35.0M | $19.2M | ||
| Q1 25 | $32.6M | $14.7M | ||
| Q4 24 | $30.1M | $4.5M | ||
| Q3 24 | $28.1M | $26.1M | ||
| Q2 24 | $27.0M | $14.4M | ||
| Q1 24 | $25.9M | $13.8M |
净利润OUSTRXRX
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $-21.7M | $-162.3M | ||
| Q2 25 | $-20.6M | $-171.9M | ||
| Q1 25 | $-22.0M | $-202.5M | ||
| Q4 24 | — | $-178.9M | ||
| Q3 24 | $-25.6M | $-95.8M | ||
| Q2 24 | $-23.9M | $-97.5M | ||
| Q1 24 | $-23.8M | $-91.4M |
毛利率OUSTRXRX
| Q4 25 | 60.2% | 59.8% | ||
| Q3 25 | 42.1% | -183.8% | ||
| Q2 25 | 45.2% | -4.9% | ||
| Q1 25 | 41.3% | -48.0% | ||
| Q4 24 | 43.8% | -181.4% | ||
| Q3 24 | 38.3% | 53.7% | ||
| Q2 24 | 33.7% | 36.2% | ||
| Q1 24 | 28.6% | 19.1% |
营业利润率OUSTRXRX
| Q4 25 | 1.5% | -304.8% | ||
| Q3 25 | -61.4% | -3327.6% | ||
| Q2 25 | -76.5% | -916.8% | ||
| Q1 25 | -73.0% | -1297.9% | ||
| Q4 24 | -85.1% | -4042.4% | ||
| Q3 24 | -98.0% | -377.1% | ||
| Q2 24 | -93.6% | -697.4% | ||
| Q1 24 | -99.5% | -698.4% |
净利率OUSTRXRX
| Q4 25 | — | -304.2% | ||
| Q3 25 | -55.0% | -3135.3% | ||
| Q2 25 | -58.8% | -894.2% | ||
| Q1 25 | -67.5% | -1373.3% | ||
| Q4 24 | — | -3935.5% | ||
| Q3 24 | -91.1% | -367.5% | ||
| Q2 24 | -88.4% | -676.6% | ||
| Q1 24 | -91.9% | -662.4% |
每股收益（稀释后）OUSTRXRX
| Q4 25 | $0.10 | $-0.17 | ||
| Q3 25 | $-0.37 | $-0.36 | ||
| Q2 25 | $-0.38 | $-0.41 | ||
| Q1 25 | $-0.42 | $-0.50 | ||
| Q4 24 | $-0.46 | $-0.56 | ||
| Q3 24 | $-0.54 | $-0.34 | ||
| Q2 24 | $-0.53 | $-0.40 | ||
| Q1 24 | $-0.55 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $208.6M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $261.7M | $1.1B |
| 总资产 | $349.5M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资OUSTRXRX
| Q4 25 | $208.6M | $743.3M | ||
| Q3 25 | $244.5M | $659.8M | ||
| Q2 25 | $226.5M | $525.1M | ||
| Q1 25 | $168.2M | $500.5M | ||
| Q4 24 | $172.0M | $594.4M | ||
| Q3 24 | $151.4M | $427.6M | ||
| Q2 24 | $184.2M | $474.3M | ||
| Q1 24 | $187.8M | $296.3M |
总债务OUSTRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益OUSTRXRX
| Q4 25 | $261.7M | $1.1B | ||
| Q3 25 | $247.4M | $1.0B | ||
| Q2 25 | $221.0M | $919.1M | ||
| Q1 25 | $167.9M | $933.9M | ||
| Q4 24 | $180.9M | $1.0B | ||
| Q3 24 | $171.7M | $524.6M | ||
| Q2 24 | $170.6M | $584.4M | ||
| Q1 24 | $167.2M | $401.2M |
总资产OUSTRXRX
| Q4 25 | $349.5M | $1.5B | ||
| Q3 25 | $353.8M | $1.4B | ||
| Q2 25 | $321.8M | $1.3B | ||
| Q1 25 | $268.6M | $1.3B | ||
| Q4 24 | $276.1M | $1.4B | ||
| Q3 24 | $255.2M | $726.5M | ||
| Q2 24 | $309.9M | $775.9M | ||
| Q1 24 | $317.7M | $557.8M |
负债/权益比OUSTRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.4M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-37.2M | $-47.3M |
| 自由现金流率自由现金流/营收 | -59.8% | -133.1% |
| 资本支出强度资本支出/营收 | 35.0% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-64.8M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流OUSTRXRX
| Q4 25 | $-15.4M | $-46.1M | ||
| Q3 25 | $-18.3M | $-117.4M | ||
| Q2 25 | $-1.3M | $-76.4M | ||
| Q1 25 | $-4.9M | $-132.0M | ||
| Q4 24 | $-2.6M | $-115.4M | ||
| Q3 24 | $-3.8M | $-59.2M | ||
| Q2 24 | $-21.6M | $-82.2M | ||
| Q1 24 | $-5.7M | $-102.3M |
自由现金流OUSTRXRX
| Q4 25 | $-37.2M | $-47.3M | ||
| Q3 25 | $-20.0M | $-117.6M | ||
| Q2 25 | $-2.2M | $-79.6M | ||
| Q1 25 | $-5.4M | $-133.8M | ||
| Q4 24 | $-4.0M | $-116.7M | ||
| Q3 24 | $-4.3M | $-63.8M | ||
| Q2 24 | $-22.0M | $-83.4M | ||
| Q1 24 | $-7.1M | $-109.0M |
自由现金流率OUSTRXRX
| Q4 25 | -59.8% | -133.1% | ||
| Q3 25 | -50.7% | -2272.5% | ||
| Q2 25 | -6.3% | -413.9% | ||
| Q1 25 | -16.6% | -907.4% | ||
| Q4 24 | -13.3% | -2567.7% | ||
| Q3 24 | -15.4% | -244.6% | ||
| Q2 24 | -81.5% | -578.5% | ||
| Q1 24 | -27.4% | -789.9% |
资本支出强度OUSTRXRX
| Q4 25 | 35.0% | 3.5% | ||
| Q3 25 | 4.3% | 4.7% | ||
| Q2 25 | 2.5% | 16.4% | ||
| Q1 25 | 1.7% | 12.4% | ||
| Q4 24 | 4.8% | 28.6% | ||
| Q3 24 | 2.0% | 17.5% | ||
| Q2 24 | 1.3% | 8.2% | ||
| Q1 24 | 5.3% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
